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Naphthomycins (NATs) are 29-membered naphthalenic ansamacrolactam antibiotics with
antimicrobial and antineoplastic activities. Their biosynthesis starts from 3-amino-5-hydroxy-
benzoic acid (AHBA). By PCR amplification with primers for AHBA synthase and amino-
dehydroquinate (aDHQ) synthase, a genomic region containing orthologs of these genes was
identified in Streptomyces sp. CS. It was confirmed to be involved in naphthomycin biosynthesis
by deletion of a large DNA fragment, resulting in abolishment of naphthomycin production.
A 106 kb region was sequenced, and 32 complete ORFs were identified, including five
polyketide synthase genes, eight genes for AHBA synthesis, and putative genes for modification,
regulation, transport or resistance. Targeted inactivation and complementation experiments
proved that the halogenase gene nat1 is responsible for the chlorination of C-30 of NATs.
The nat1 mutant could also be complemented with asm12, the halogenase gene of ansamitocin
biosynthesis. Likewise, an asm12 mutant could be complemented with nat1, suggesting a similar
catalytic mechanism for both halogenases. A putative hydroxylase gene, nat2, was also
inactivated, whereupon the biosynthesis of NATs was completely abolished with a tetraketide
desacetyl-SY4b accumulated, indicating the participation of nat2 in the formation of the
naphthalene ring. The information presented here expands our understanding of the biosynthesis
of naphthalenic ansamycins, and may pave the way for engineering ansamacrolactams with
improved pharmaceutical properties.
Introduction
The naphthomycins (NATs) (Fig. 1A) belong to the family of
ansamycin antibiotics, whose characteristic structure comprises
an aromatic moiety bridged at nonadjacent positions by an
aliphatic chain.1 The aromatic moiety can either be a naphthalene
or naphthoquinone ring system, as in rifamycin2 and naphtho-
mycin, or a benzene or benzoquinone ring, as in geldanamycin3
and ansamitocin.4 The biosynthesis of ansamycin antibiotics
involves the assembly of a polyketide from an unusual starter
unit, 3-amino-5-hydroxy-benzoic acid (AHBA),5 by chain
extension with several acetate and propionate units catalyzed by
a type I polyketide synthase (PKS). The starter unit AHBA is
synthesized via a variant of the shikimate pathway for aromatic
amino acid biosynthesis (Fig. 1B).6,7
NATs are 29-membered ansamacrolactams with the largest
ring reported so far in the ansamycin family. Not only carry-
ing the characteristic naphthalene ring and the shifted double
bond at C12–13, NATs also have a featured triene and there is
chlorination on the AHBA moiety of certain NATs. More-
over, a variety of nuclear substituents, including methyl,
hydroxyl, methoxy, chloro and alkylthio groups, are present
at the C-30 of NATs (Fig. 1A). They display significant
antimicrobial and antineoplastic activities. Naphthomycin A
and B are inhibitors of fatty acid synthesis with selective
toxicity against prokaryotes,8 whereas the cytotoxicity of
naphthomycin A is exerted through the inhibition of various
SH-enzymes, particularly those involved in nucleic acid bio-
synthesis.9 NATs have been isolated from different Streptomyces
strains, including NAT A from S. diastatochromogenes Tü 105,10
NAT B from S. galbus subsp. griseosporueus Tü 353, NAT C
from S. collinus Tü 1892,11 NAT H from Streptomyces sp.
Y83,12 and NAT I and J from Streptomyces sp. E/784.13
Recently, an endophytic Streptomyces, isolated from the
medicinal plant Maytenus hookeri, namely Streptomyces sp.
CS (hereafter called CS), was found to be the producer of
naphthomycin A, C, E and K.14
Previous isotope-labeled feeding experiments clearly revealed
that the backbone of NATs is assembled by a type I PKS from
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seven propionate and six acetate chain extender units,15 using
AHBA as the starter unit. Through Southern hybridization
with rifK, encoding the AHBA synthase of rifamycin bio-
synthesis7 as a probe, a portion of PKS and two complete sets
of AHBA biosynthetic genes were cloned from S. collinus
Tü 1892.16 However, the involvement of these genes in
naphthomycin biosynthesis has not been confirmed genetically
or biochemically. Herein, we report the cloning and
sequencing of the naphthomycin biosynthetic gene cluster
(nat) from CS, and the investigation of a halogenase gene and
a hydroxylase gene required for naphthomycin biosynthesis.
Results
Cloning and identification of the naphthomycin biosynthetic
gene cluster
The only reaction in the proposed biosynthetic pathway of
AHBA, which has no analogy in the normal shikimate pathway,
is the aromatization of aminoDHS by a postulated AHBA
synthase. The AHBA synthase gene then served as a probe
allowing the cloning of gene clusters for the biosynthesis
of many AHBA-derived antibiotics, such as ansamitocin,17
geldanamycin,18 and mitomycin.19 Since AHBA synthase is
Fig. 1 Naphthomycins and the biosynthesis of AHBA. (A) Structures of naphthomycins. (B) Proposed AHBA biosynthetic pathway. aF6P,
amino-fructose-6-phosphate; iminoE4P, imino-erythrose-4-phosphate; aDAHP, amino-3-deoxy-D-arabino-heptulosonate-7-phosphate; aDHQ,
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highly conserved in the biosynthesis gene clusters of different
ansamycins, degenerate primers for AHBA synthase were used
to clone the naphthomycin gene cluster from Streptomyces sp.
CS (Fig. S1, ESIw). Fifteen fosmids were identified from a
genomic library of CS, which gave products of the expected
size. These were further investigated by PCR using a pair of
primers specific for napC, the amino-dehydroquinate (aDHQ)
synthase gene expected to be involved in naphthomycin C
biosynthesis.16 Eventually, 11 overlapping fosmids including
fosmid 14F11 were identified, carrying homologs of AHBA
synthase and aDHQ synthase genes.
In order to confirm the involvement of the region covered
by these fosmids in naphthomycin biosynthesis, a 7.2 kb
region was replaced by the apramycin resistant gene aac(3)IV
in CS. The mutants displayed a complete loss of naphthomycin
production on ISP3 medium, confirming the involvement of
this region in naphthomycin biosynthesis (Fig. S2, ESIw). Two
more fosmids 4C11 and 23G9 were identified by sequential
chromosome walking (Fig. 2A), and sequenced together with
14F11. The three fosmids covered a 106 kb region and contained
32 complete open reading frames (ORFs) (Fig. 2B). The
predicted functions of these genes are shown in Table 1.
The nat PKS genes
Five modular type I PKS genes, nat A–E, are arranged in
co-linearity with the predicted assembly of the polyketide
backbone, totally encoding one loading module and thirteen
extension modules as required for loading of the AHBA
starter unit and incorporation of 7 propionate and 6 acetate
units. However, two ketoreductase (KR) domains and six
dehydratase (DH) domains are predicted to be redundant as
deduced from the naphthomycin structure (Fig. 2B and 6).
NatA contains a loading domain, consisting of an acyl
carrier protein (ACP) and an adenylation domain (ADE),
presumably required for the activation of the AHBA starter
unit, and the modules 1–3 for naphthomycin polyketide chain
extension. The DH domains of module 1 and module 2 are
unusually small with a size of 144 aa and 142 aa, respectively,
suggesting both domains are inactive.20 In the KR domain of
module 3, the conserved catalytic Y residue21 is mutated to S,
which could abolish the ketoreductase activity.
NatB contains modules 4–6 for the incorporation of two
propionate and one acetate units. However, even though the
sequence of the DH domain of module 5 seems functional, no
dehydration is required in this extension step, as judged from
the structure of naphthomycin. NatC hosts modules 7–9 and is
expected to catalyze the incorporation of an acetate, a
propionate, and a further acetate unit, respectively. Similar
to the DH domain of module 5, the DH domain of module 7
seems functional but is not required in naphthomycin
biosynthesis. Moreover, even though the sequences of the
KR and DH domains of module 9 seem functional, both of
them are not required for this specific extension step.
NatD is a bi-modular protein, presumably for the
incorporation of one propionate and one acetate unit.
Fig. 2 Gene organization of the naphthomycin biosynthetic gene cluster. (A) overlapping inserts of 3 fosmid clones used for sequencing. P1, PCR
probe used for screening of the genomic library; P2 and P3, PCR probes for sequential chromosome walking of naphthomycin biosynthetic gene
cluster. (B) open reading frames deduced from the nucleotide sequence in naphthomycin biosynthetic gene cluster. KS, ketosynthase; AT,
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The DH domain of module 10 looks normal but apparently
redundant. NatE comprises modules 12 and 13 and is expected to
be responsible for the incorporation of one acetate and one
propionate (as in NAT A) or acetate (as in NAT C) units to
complete the polyketide assembly. While the typical propionate-
specific motif is YASH for AT,22 the motif of AT13 is YPSH,
whichmay cause the leaky recognition of the acetate extender unit.
Located immediately downstream of natE is natF, which
encodes a protein with a high homology to RifF, the enzyme
responsible for the polyketide chain-release and cyclization of
rifamycin biosynthesis.23 The fully extended polyketide chain
of naphthomycin is proposed to be transferred from NatE to
NatF, followed by intra-molecular amide bond formation to
release a 29-membered pronaphthomycin (Fig. 6).
The nat AHBA biosynthetic genes
Eight AHBA biosynthetic genes, nat G-N, were identified in
the naphthomycin gene cluster from CS (Fig. 2B). Of these,
the seven genes natGHIKLMN are apparently organized into a
single operon, while the putative aDHQ dehydratase gene natJ
is located 4.2 kb downstream of natN (Fig. 1B). These genes
had been shown to be involved in naphthomycin biosynthesis
through the aforementioned large fragment deletion. The
organization and sequence of them show significant homology
with other naphthalenic ansamycins, especially rifamycin and
naphthomycin C (Fig. S3A, ESIw). According to the well-
studied biosynthetic mechanism of AHBA in rifamycin
(Fig. 1B), these homologous genes in naphthomycin may carry
Table 1 Deduced functions of ORFs in naphthomycin biosynthetic gene cluster
Polypeptide
Amino





Orf1 567 ATP/GTP-binding protein SAV_1815, S. avermitilis MA-4680 82/91 NP822991
Orf2 711 ATP/GTP-binding protein SAV_1814, S. avermitilis MA-4680 68/79 NP822990
Orf3 47 Conserved hypothetical protein SSEG_07125, S. sviceus ATCC 29083 62/70 YP002202776
Orf4 97 Protoporphyrinogen oxidase Noca_3672, Nocardioides sp. JS614 37/1 YP924859
Orf5 442 Transcriptional regulator ORF36, A. mediterranei S699 40/56 AAS00758
Orf6 211 Acyl carrier protein phosphodiesterase acpD, S. avermitilis MA-4680 43/59 NP825521
Orf0 397 Cytochrome P450-like protein ORF0, A. mediterranei S699 65/79 AAC01709
NatA 5698 PKS RifA, A. mediterranei S699 66/75 ABB86419
Loading ADE ACP AAC01710
Module 1 KS AT DH* KR ACP
Module 2 KS AT DH* ACP
Module 3 KS AT KR* ACP
NatB 5339 PKS RifB, A. mediterranei S699 65/74 AAC01711
Module 4 KS AT DH KR ACP
Module 5 KS AT DH* KR ACP
Module 6 KS AT DH KR ACP
NatC 5321 PKS RifB, A. mediterranei S699 58/69 AAC01711
Module 7 KS AT DH* KR ACP
Module 8 KS AT DH KR ACP
Module 9 KS AT DH* KR* ACP
NatD 3621 PKS RifE, A. mediterranei S699 59/69 AAC01714
Module 10 KS AT DH* KR ACP
Module 11 KS AT DH KR ACP
NatE 3533 PKS RifE, A. mediterranei S699 58/69 AAC01714
Module 12 KS AT DH KR ACP
Module 13 KS AT DH KR ACP
NatF 289 Amide synthase RifF, A. mediterranei S699 51/64 AAC01715
Nat1 447 Halogenase Asm12, Ac. pretiosum ATCC31565 61/73 AAM54090
NatG 353 3-Dehydroquinate synthase RifG, A. mediterranei S699 74/80 AAC01717
NatH 478 DAHP synthase RifH, A. mediterranei S699 58/70 AAF70331
NatI 281 Shikimate/quinate dehydrogenase RifI, A. mediterranei S699 70/78 AAC01719
NatK 386 3-Amino-5-hydroxy benzoic acid synthase RifK, A. mediterranei S699 82/88 AAC01720
NatL 364 Oxidoreductase RifL, A. mediterranei S699 67/78 AAS07754
NatM 231 Phosphatase RifM, A. mediterranei S699 71/83 AAC01721
NatN 306 Glucose kinase RifN, A. mediterranei S699 60/73 AAC01722
Nat2 585 FAD-dependent oxidoreductase ORF19, A. mediterranei S699 66/75 AAG52989
NatR 257 Thioesterase RifR, A. mediterranei S699 6478 AAG52991
Nat4 461 Membrane ion antiporter ORF7, A. balhimycina 58/74 CAC48373
NatJ 146 Aminodehydroquinate dehydratase RifJ, A. mediterranei S699 78/88 AAS07762
Nat5 230 Alpha/beta fold family protein UBAL2_80490237, Leptospirillum sp. 26/44 EAY56956
Nat6 187 Activator of Hsp90 ATPase RHE_CH02426, Rhizobium etli CFN
42
37/54 YP469931
Nat7 476 Metallopeptidase SAV_3952, S. avermitilis MA-4680 55/67 NP825129
Nat8 252 GntR family transcriptional regulator SAV_3189, S. avermitilis MA-4680 72/81 NP824365
Nat9 529 Amino acid permease YbeC, Bacillus amyloliquefaciens
FZB42
56/76 YP001419888
Nat10 138 Hydrolase SAV_3187, S. avermitilis MA-4680 71/82 NP824363
Nat11 870 Magnesium or manganese-dependent
phosphatase
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out similar functions to catalyze the formation of AHBA from
UDP-glucose.24
Genes for the post-PKS modifications
Compared to other ansamycins, the post-PKS modifications
of naphthomycins are relatively simple. Nat1 shows 61%
identity to the halogenase Asm12 for ansamitocin bio-
synthesis, and is considered to be responsible for the chlorination
at C-30 in naphthomycin A formation. Nat2 shows 61%
identity with Rif-orf19, a 3-(3-hydroxyphenyl) propionate
hydroxylase in rifamycin, and is predicted to be involved in
the formation of the naphthalene ring of naphthomycins
during the polyketide chain elongation (Fig. 6). Orf0 shows
sequence similarity to cytochrome P450 monooxygenase and
may be involved in the oxidation steps required for the
formation of some naphthomycins.
Inactivation of halogenase gene nat1
In order to confirm the possible role of nat1 for halogenation
at C-30, an 8.24 kb BamHI/EcoRI fragment from fosmid
14F11 carrying this gene was cloned. An internal 1344 bp
region of nat1 was replaced by an apramycin resistance gene,
resulting in plasmid pJTU3245, with 3.24 kb left-flanking and
3.72 kb right-flanking sequences of the deletion (Fig. 3A). This
plasmid was introduced into the wild-type CS strain by conjuga-
tion. Five double cross-over mutants (WYY2-1–WYY2-5) were
obtained. PCR amplification usingNat1-Det-F andNat1-Det-R as
primers confirmed that they gave the expected 1.48 kb PCR
product without NcoI restriction site, while the PCR fragment
derived from the wild-type was 1.35 kb in size and could be
digested into a 0.82 kb fragment and a 0.53 kb fragment by NcoI
(Fig. 3B). LC-MS analysis of the fermentation broth showed that
in mutant WYY2 the chlorinated component naphthomycin A
Fig. 3 Inactivation and complementation of halogenase gene nat1. (A) schematic representation of the nat1 inactivation. (B) verification of the
genotype through PCR amplification. Lane 1 and 6, DNA ladder; lane 2, PCR product of the wild-type; lane 3, PCR product of the mutant
WYY2; lane 4, PCR product of the wild-type digested with NcoI; lane 5, PCR product of the mutant WYY2 digested with NcoI. (C), HPLC
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was no longer produced, while naphthomycin E, the 30-deschloro-
naphthomycin component, could clearly be detected (Fig. 3C).
Cross-complementation between the halogenase genes of
naphthomycin and ansamitocin biosynthesis
The inactivation of the nat1 gene had shown that nat1 is
responsible for the chlorination reaction at C-30 of naphtho-
mycins (Fig. 4A). Nat1 shared high sequence identity (73%)
with the previously identified halogenase Asm12 for the
biosynthesis of ansamitocin.17 Inactivation of asm12 gave mutant
HGF054, which no longer produced ansamitocin-P3, but
accumulated a series of 19-deschloro-ansamitocin derivatives.25
The reaction catalyzed by Asm12 was proposed to be modifica-
tion of ansamitocins (Fig. 4A). Both nat1 and asm12 contain two
conserved sequence motifs ‘‘GXGXXG’’ and ‘‘WXWXIP’’,
typical of FADH2-dependent halogenase (Fig. S4, ESIw).
26,27
To further investigate whether Nat1 and Asm12 catalyze the
similar reaction, a cross complementation experiment using
Fig. 4 Cross complementation between halogenase genes nat1 and asm12. (A) proposed chlorination reactions in the biosynthesis of ansamitocins and
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nat1 and asm12 was carried out. Plasmids pJTU3243 and
pJTU3244, harboring asm12 and nat1, respectively, under
the control of the strong constitutive PermE* promoter, were
introduced into the asm12 mutant HGF054 by conjugation.
Both nat1 and asm12 complemented the production of
ansamitocin AP-2, AP-3 and AP-4 to about 100% of the
wild-type level (Fig. 4B). The plasmids pJTU3246 and
pJTU3247, carrying asm12 and nat1, respectively, were also
introduced into the nat1 mutant WYY2 similarly, and both
complemented the naphthomycin A production to about 20%
of the wild-type level (Fig. 4C).
Involvement of Nat2 in naphthalene ring formation
The possible involvement of nat2 in the formation of a
naphthalene ring was examined by gene replacement and
complementation. In the plasmid pJTU1289, a 980 bp internal
fragment of nat2 was replaced by the apramycin-resistance
gene aac(3)IV, inserted between a 3.94 kb left-flanking and a
3.98 kb right-flanking sequence, resulting in plasmid pJTU3250
(Fig. 5A). Four thiostrepton-sensitive and apramycin-resistant
(ThioS AprR) recombinant mutants (WYY3-1–WYY3-4) were
obtained. Total DNAs from these mutants and the wild-type were
used as templates for PCR analysis with primers Nat2-Det-F and
Nat2-Det-R. The wild-type gave the expected 1.0 kb PCR product
without MluI site, whereas the mutants gave a 1.3 kb PCR
product, which could be digested by MluI into a 1.0 kb fragment
and a 0.3 kb fragment (Fig. 5B). LC-MS analysis of the
fermentation extract of the mutant strains showed a complete
abolishment of the production of all the naphthomycins
(Fig. 5C). As expected, the mutant produced desacetyl-SY4b
Fig. 5 Inactivation and complementation of the putative hydroxylase gene nat2. (A) schematic representation of the nat2 inactivation.
(B) verification of the genotype through PCR amplification. Lane 1, DNA ladder; lane 2, PCR product of the wild-type; lane 3, PCR product
of the mutant WYY3. (C) HPLC analysis of the fermentation broth of the wild-type, nat2 mutant WYY3, and WYY3 complemented with cloned
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as detected by LC-MS analysis (Fig. 5C & D), which is identical
to the compound isolated from the rif-orf19 mutant derived
from rifamycin producer Amycolatopsis mediterranei S699.28,29
Further support for the involvement of Nat2 in naphthalene
ring formation came from complementation of the mutant
WYY3 with nat2 and rif-orf19, respectively. LC-MS analysis
of the extract of complemented mutants showed the production
of naphthomycins was almost fully restored by nat2, and to
about 30% of the wild-type level by rif-orf19 (Fig. 5C).
Additionally, nat2was introduced into HGF065, a proansamitocin
producer with mutated asm12 and asm21, to detect if there was
any new derivative with a naphthanene ring or oxygenated
derivative of proansamitocin. However, no detectable peak for
expected compounds was observed in the complemented
strains with nat2 (data not shown).
Discussion
A few biosynthetic gene clusters of ansamycins had been
identified and sequenced, including rifamycin and rubradirin
in the naphthalenic family, and ansamitocin, geldanamycin,
and herbimycin of the benzenic family. Since their AHBA
synthase genes had been verified to be conserved in ansamycins
(Fig. S1, ESIw), the naphthomycin biosynthetic gene cluster in
CS was obtained by PCR screening using degenerate primers
designed from rifK and other AHBA biosynthetic genes.
Compared to other ansamycins, the arrangement of gene
cluster and chemical structures of naphthomycins are very
similar to rifamycin from Amycolatopsis mediterranei S699,
suggesting a close genetic relationship between the biosynthesis
of naphthomycin and rifamycin. As in rifamycin, eight genes
are proposed to be involved in the biosynthesis of the AHBA
unit for naphthomycin (Fig. 2). The gene natI, homologous
with rifI, putatively encodes aminoquinate dehydrogenase to
regulate the AHBA pool to prevent the uncontrolled
accumulation of AHBA in the cell (Fig. S3A, ESIw).24
Additionally, the organizations of AHBA biosynthetic genes
and the AHBA synthases show prominent differences between
naphthalenic and benzenic ansamycin biosynthetic genes
(Fig. S3A and S3B, ESIw).
Surprisingly, extreme redundancy of reduction domains
were identified in nat polyketide synthase as deduced from
the structure of NATs. Among 13 elongation modules, 2
ketoreductase (KR) and 6 dehydratase (DH) domains were
found to be redundant in 7 modules including module 1, 2, 3,
5, 7, 9, and 10 (Fig. 2B and 6). Interestingly, the redundancy of
reductive domains is found to be prevalent in the PKS for
naphthalenic ansamycin biosynthesis. In rifamycin PKS, five
DH domains and 1 KR domain in 7 of the 10 elongation
modules were found to be redundant for the biosynthesis of
the 25-membered rifamycin B.23 Moreover in rubradirin PKS,
3 DH domains and 2 KR domains in 4 of the 6 elongation
modules were identified to be not required for the biosynthesis
of the 15-membered rubradirin.30 However, the redundant
domain has so far not been found in the published PKSs for
the biosynthesis of benzenic ansamycins including ansamitocin,
geldanamycin, and herbimycin.17,18,31 Although the redundant
domains are not likely to be functional for the PKS structure,
it is proposed that they could retain the structural and
catalytic integrity as stand-alone PKS proteins.32
In nature, the presence of halogenation usually improves the
biological activity of secondary metabolites.33 In ansamycins,
both Nat1 for naphthomycin and Asm12 for ansamitocin
biosynthesis were categorized to be flavin-dependent
Fig. 6 Putative naphthomycin biosynthetic pathway. ADE, carboxylic acid: ACP ligase (loading domain); KS, b-ketoacyl-ACP synthase; DH,
b-hydroxyacyl-thioester dehydratase; KR, b-ketoacyl-ACP reductase; ER, enoyl reductuase. The putative intermediates in chain-extension cycles
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halogenases. The flavin-dependent halogenases are usually
two-component systems, in which a flavin reductase is
required to regenerate the FADH2 for catalytic turnover.
34 Since
gene deletion study suggested Asm12 catalyzes the first step of
ansamitocin post-polyketide modification, further research
into the detailed function of Asm12 is needed. The successful
cross complementation experiment points to a similar substrate
for Nat1 and Asm12 in the biosynthesis of naphthomycins and
ansamitocins, respectively. However, expected products of
chloro-proansamitocin and naphthomycin A could not be
detected in vitro using the predicted substrates of proansamitocin
and naphthomycin E with purified Asm12 and Nat1, respectively
(data not shown). One possibility is that the substrates for
Nat1 and Asm12 could be ACP-bound intermediates. The
other explanation is the rapid decomposition of free FADH2
with molecular oxygen into FAD and H2O2, which leads to a
significant decrease in halogenase activity.34
The nat2 gene, putatively encoding a 3-(3-hydroxyphenyl)-
propionate hydroxylase and homologous to Rif-Orf19 in
rifamycin23 and RubP1 in rubradirin,30 was proposed to be
involved in the naphthalene ring formation of naphthomycins.
Since the disruption of rif-orf19 ceased production of
rifamycin B and caused the accumulation of the tetraketides
SY4b and desacetyl-SY4b, Rif-Orf19 was assumed to introduce
a hydroxyl group into the acyl carrier protein (ACP)-bound
tetraketide. This sets the stage for further enzymatically
catalyzed or spontaneous cyclization reaction to form the
naphthalene ring. However, whether a single enzyme or a
complex group of enzymes is responsible for the entire process
remains to be investigated.29 In Streptomyces CS, disruption
of nat2 abolished the production of all the naphthomycin
components and accumulated tetraketide desacetyl-SY4b.
Moreover, both nat2 and rif-orf19 could complement the
production of naphthomycins in the nat2 mutant, implicating
the role of Nat2 in the biosynthesis of naphthalene ring
formation. Besides naphthalenic ansamycins, nat2 homologs
had been reported to be involved in the oxidation of benzenic
ansamycins, such as gdmM andmcbM from geldanamycin and
macbecin biosynthetic gene cluster, respectively.18,35 In silico
analysis of the amino acid sequences revealed that all the
proteins within this family contain typical nucleotide-binding
motifs GXGXXG (motif I), DGXXSXXR (motif II) and
GDXXH (motif III) for flavoprotein hydroxylases (Fig. S5A,
ESIw).36,37 Similar to the AHBA synthases, these hydrolases
could be divided into two distinct clades either for naphthalenic
or benzenic ansamycin biosynthesis by phylogenetic analysis,
reflecting divergent biosynthetic routes for these two subgroups
of ansamycins (Fig. S5B, ESIw).
Deduced from the abovementioned results, the biosynthetic
pathway for naphthomycin A was proposed (Fig. 6). Initiated
with the AHBA starter unit, the polyketide backbone of
naphthomycin A is extended with the incorporation of 2
methyl-malonyl-CoA and 1 malonyl-CoA to generate a tetraketide
tethered to the ACP of module 3. The discrete four-module
NatA and three-module NatB may provide an inter-molecule
space allowing the accessibility and the oxidation of the
tetraketide intermediate by Nat2, followed with an spontaneous
intra-molecular cyclization to form the naphthalene ring.29
The tetraketide with naphthalene ring is then extended with
5 methyl-malonyl-CoA and 5 malonyl-CoA extender units,
producing a linear polyketide chain tethered to the ACP of
module 13. Subsequently, the nascent polyketide chain is
transferred, hydrolyzed, and cyclized by the amide synthase
NatF to form the 29-membered pronaphthomycin. Even
though no obvious dehydratase gene is identified in the nat
gene cluster, a dehydration step, rather than the proposed
dehydrogenation in rifamycin biosynthesis, is required for the
aromatization of the naphthalene ring to generate NAT E.
Finally, NAT E is converted to NAT A through chlorination
catalyzed by Nat1 (Fig. 6).
Experimental procedures
Materials and general methods
Streptomyces CS14 was grown at 30 1C in TSBY medium (3%
TSB, 1% yeast extract, 10.3% sucrose, pH 7.2, w/v) for liquid
cultivation and on ISP3 agar plates (2% agar, 20% oatmeal, 1 ml
trace element solution, pH 7.2, w/v) supplemented with 1% w/v
leave extract of Maytenus austroyunnanensis and 0.6% (w/v)
KNO3. E. coli DH10B (Invitrogen) and ET12567/pUZ8002
38
were used throughout the study as a cloning host and transient
host for conjugation, respectively.E. coliEPI300t (EPICENTRE)
was used for genomic library construction and routine fosmid
preparations. E. coli strains were grown at 37 1C in LB broth
and LB agar. Media were supplemented with appropriate
antibiotic concentrations as follows: ampicillin (100 mg ml1),
kanamycin (25 mgml1), chloramphenicol (25 mgml1), apramycin
(30 mg ml1) and thiostrepton (25 mg ml1). The strains and
plasmids used in this study are listed in Table S1, ESI.w
Synthesis of oligonucleotide primers and sequencing of PCR
products were performed by Shanghai Sangon or Invitrogen
Co., Ltd. Extraction of DNA fragments from agarose gel slices
was performed with the Gel Recovery Kit (Tiangen). Sequence
assembly into contigs was performed using Vector NTI 11.0
software (Invitrogen). ORF predictions were made using
Framplot 3.0 Beta (http://watson.nih.go.jp/Bjun/cgi-bin/fra
meplot-3.0b.pl) and the Genemark. hmm algorithm
(http://exon.biology.gatech.edu/). Domain prediction of poly-
ketide synthase was conducted with SBSPKS.39 Conjugation
between E. coli and Streptomyces CS were performed as
described by Kieser et al.40
Fosmid library construction and screening
Total DNAs were isolated from Streptomyces strains as
described by Kieser et al.40 Total DNA was sheared and
ligated into CopyControl pCC1FOS vector (EPICENTRE).
The ligated mixture was Packed with MaxPlax Lambda
Packaging Extracts and transduced into E. coli EPI300t
(EPICENTRE) to generate the genomic library. The library
was first screened by PCR using degenerated primers for
AHBA synthase gene, i.e., AHBAF (50-CCSGCCTTCACC-
TTCATCTCCTC-3 0) and AHBAR (50-AYCCGGAACATS-
GCCATGTAGTG-3 0). In subsequent screening steps, specific
primers based on the identified sequence of the AHBA
synthase of naphthomycin C biosynthesis, napCF (50-GTCA-
GCGTGACGCTCAAGGC-3 0) and napCR (50-AGCCCG-
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cluster was obtained by sequential chromosome walking
through PCR amplification.
Gene inactivation
Gene inactivation was carried out by REDIRECTs Technology.
A 1.40 kb fragment of pIJ773 carrying the apramycin resistant
gene aac(3)IV was routinely used as the template for the PCR
amplification for gene disruption.41 Detailed plasmid construc-
tion is described in the ESI.w The three constructs, pJTU3231,
pJTU3245 and pJTU3250 were delivered into Streptomyces sp.
CS by conjugation from E. coli. The apramycin-resistant and
thiostrepton-sensitive recombinants were selected for further
verification. Genomic DNA was isolated from the wild-type
and the mutants and used as the templates for PCR amplifica-
tion. The mutants of large fragment deletion, nat1, and nat2were
named as WYY1, WYY2 and WYY3, respectively.
Cross complementation of halogenase genes nat1 and asm12
The nat1 gene was amplified with KOD-plus DNA polymerase
using fosmid 14F11 as a template and primers Nat1-F (50-AAA-
GGATCCTCATATGAGCGACAACTCGACCGA-3
0, with
engineered BamHI and NdeI underlined) and Nat1-R (50-AAA-
GAATTCTACTGGCCTTGGGTCACCCGTC-3
0, with engi-
neered EcoRI underlined). The asm12 gene was amplified from
the genomic DNA of A. pretiosum using primers Asm12-F
(50-AAAGGATCCTCATATGCTCGACGCGATCGTGAT-3
0,
with engineered BamHI and NdeI underlined) and Asm12-R
(50-AAAGAATTCACCGGCCGACCGTGCCCG-3
0, with engi-
neered EcoRI underlined). The resultant PCR products were
purified, ligated into pMD-18 (Takara), and sequenced to
validate the inserted DNA sequence. For the complementation
of the nat1 mutant, nat1 and asm12 were transferred to
pJTU824 digested with NdeI and EcoRI to generate
pJTU3247 and pJTU3246, respectively. These two plasmids
were individually introduced into WYY2 through conjuga-
tion, and thiostrepton-resistant exconjugants were selected.
For the complementation of asm12mutant HGF054, nat1 and
asm12 were transferred to pIJ139 digested with NdeI and
EcoRI to generate pJTU3244 and pJTU3243, respectively. These
two plasmids were individually introduced into HGF054
through conjugation, and thiostrepton-resistant exconjugants
were selected.
Complementation of WYY3 or asm12/21 mutant with cloned
nat2 or rif-orf19
The nat2 gene was amplified using the following primers:
Nat2-F (50-AAAGGATCCTCATATGTCGCCGGGCCG-
TACGCTC-3 0) with engineered BamHI and NdeI sites under-
lined and Nat2-R (50-AAAGAATTCTCAGTCGGCGCGG-
CCCGCGGG-3 0), with the engineered EcoRI site underlined.
The rif-orf19 gene was amplified using the following primers:
Orf19-F (50-AAAGGATCCTCATATGACGGACACGGA-
CGTCGTC-30), with engineered BamHI and NdeI sites under-
lined and Orf19-R (50-AAAGAATTCCTAGCCGGTGGGC-
ACCGCGGC-30), with the engineered EcoRI site underlined.
For the complementation of the nat2 mutant, nat2 and
rif-orf19 were transferred to pJTU824 digested with NdeI
and EcoRI to generate pJTU5156 and pJTU5157, respectively.
These two plasmids were individually introduced into WYY3
through conjugation, and thiostrepton-resistant exconjugants
were selected. For the complementation of the asm12/21 mutant
HGF065, nat2 was cloned to pIJ139 digested with NdeI and
EcoRI to generate pJTU5158. Plasmid pJTU5158 was intro-
duced into HGF065 through conjugation, and apramycin-
resistant exconjugants were selected.
Antibiotic fermentation, purification and analysis
Naphthomycin production by the wild-type and mutants was
determined as follows. TSBY medium was inoculated with spore
suspension as the seed culture. After incubation for 36 h at 30 1C
and 220 rpm, the culture was used to inoculate ISP3 agar plates,
which were incubated for 10 d at 30 1C. The culture was extracted
twice with ethyl acetate–methanol–acetate (80 : 15 : 5, v/v/v) to
afford the crude extract, which was centrifuged, dissolved in
ethanol, and directly used for LC-MS analysis. High-performance
liquid chromatography (HPLC) analysis was carried out using an
Agilent 1100 HPLC system (Agilent Technologies). The samples
were separated on a ZORBAX SB-C18 column (2.1 mm 
150 mm, particle size 3.5 mm). The column was equilibrated with
10% acetonitrile (ACN) and was developed with the following
program: 0–8 min, 10–40% ACN; 8–42 min, 40–75% ACN;
42–43 min, 75–95% ACN; 43–52 min, 95% ACN; 52–54 min,
95–10% ACN; 54–58 min, 10% ACN at a flow rate of
0.1 ml min1 and UV detection at 254 nm. Naphthomycin A is
C40H46ClNO9, with ESI-MS m/z of 720.3 [M + H]
+ or 742.3
[M+Na]+, and an HPLC retention time of 43.9 min. Naphtho-
mycin E is C40H47NO9 with ESI-MS m/z of 686.2 [M + H]
+ or
708.3 [M + Na]+, and an HPLC retention time of 38.7 min
(Fig. S6). The tetraketide desacetyl SY4b, isolated from nat2
mutant, is C15H17NO5 with ESI-MS m/z of 292.0 [M + H]
+ or
314.1 [M + Na]+, and an HPLC retention time of 23.8 min.
Ansamitocins were extracted from the solid cultures of A.
pretiosum. After incubation in TSBY medium for 24 h, the
seed culture was used to inoculate solid YMGmedium (2% agar,
0.4% yeast extract, 1% malt extract, 0.4% glucose, pH 7.2, w/v),
which was incubated for 7 d at 30 1C. HPLC analysis was carried
out using an Agilent 1100 HPLC system (Agilent Technologies).
The samples for HPLC analysis were separated by using gradient
elution (0–10 min 10–55% B, 10–20 min 55–75% B, 20–35 min
5–95% B, 35–45 min 95% B, 45–50 min 95–10% B, buffer A:
H2O with 0.5% formic acid; buffer B: methanol). This was
carried out at a flow rate of 0.1 ml min1 and UV detection at
254 nm. AP-2 is C31H41ClN2O9, with ESI-MS m/z of 621.2
[M + H]+, or 643.2 [M + Na]+, or 659.1 [M + K]+, and an
HPLC retention time of 36.2 min. AP-3 is C32H43ClN2O9,
with ESI-MS m/z of 635.3 [M+H]+, or 657.2 [M + Na]+, or
673.2 [M+K]+, and an HPLC retention time of 37.6 min. AP-4
is C31H41ClN2O9, with ESI-MSm/z of 649.3 [M+H]
+, or 671.2
[M + Na]+, or 687.2 [M + K]+, and an HPLC retention time
of 39.4 min (Fig. S6, ESIw).
Accession number
The nucleotide sequence of naphthomycin biosynthetic genes
described in this paper was deposited in the GenBank with the
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